Breaking News | YHLO Achieves Full IVDR CE Certification for the Blood Bank Panel 🎉— the First in China 🇨🇳🌍
Breaking News!!! We are thrilled to share a major milestone in YHLO's global regulatory journey that we have got the latest Class D IVDR CE certificate for our HIV assay! With this approval, YHLO has now achieved full IVDR CE certification for the entire Blood Bank Panel—including HIV, HBV(HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc), HCV, and Syphilis(Anti-TP).
This achievement makes YHLO the first company in China — and among the first globally — to obtain full IVDR CE certification for the Blood Bank panel.
Founded in 2008, YHLO is a national high-tech enterprise and specialized in R&D, production and sale of in vitro diagnostic (IVD) instruments and reagents. With our committed innovation, nowadays our multiple products have entered more than 120 countries.
YHLO will continue working hand-in-hand with glogal partners to build a healthier, better future together.
Attachments:
Previous
MORE NEWS
Meet YHLO PIFI: Smarter Islet Function Assessment
Launched on April 10 at the 2026 Islet Metabolism Forum in Nanjing, the YHLO PIFI Intelligent Computing Model marks a major step forward in diabetes care.
2026-04-14
2026 YHLO Global Partners Conference: Intelligent Automation · Infinite Potential
On March 30, 2026, YHLO Global Partners Conference was grandly held in Changsha.
2026-04-03
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
